Projects

Director
RNDr. Soňa Čačányiová, PhD.

International

Finished
  • Study of interactions between reactive oxygen species and nitric oxide in search for novel mechanisms of hypertension
    Program: Bilateral - other
    Duration: 1. 1. 2011 – 31. 12. 2013
  • The role of nitric oxide, free radicals, and AII peptide on vascular structure and function in experimental hypertension.
    Program: Bilateral - other
    Duration: 1. 3. 2010 – 31. 12. 2011

National

Current
  • Zofenopril and erucin, H2S releasing coumpounds, in therapy of cardiovascular disorder in experimental model of obesity and 2 type diabetes
    Program: VEGA
    Duration: 1. 1. 2022 – 31. 12. 2025
  • Cardiometabolic effects of Mas receptor stimulation by modulation of the renin-angiotensin system - the key role of angiotensin-converting enzyme 2
    Program: SRDA
    Duration: 1. 7. 2021 – 30. 6. 2025
  • The role of inflammation in the development of cardiovascular complications associated with metabolic syndrome and prediabetes
    Program: SRDA
    Duration: 1. 7. 2022 – 30. 6. 2025
Finished
  • Mesenteric perivascular fat and its specific role in regulation of intestinal circulation in rats with different feeding regimens
    Program: VEGA
    Duration: 1. 1. 2021 – 31. 12. 2023
  • Vazoactive effects of hydrogen sulphide signalling pathway and its interaction with nitric oxide in different animal models of metabolic syndrome
    Program: VEGA
    Duration: 1. 1. 2019 – 31. 12. 2022
  • Nitroso-sulphide signal pathway - novel regulator vasoactive effects in different types of arterial hypertension
    Program: VEGA
    Duration: 1. 1. 2018 – 31. 12. 2021
  • New perspectives in the treatment of cardiovascular complications associated with COVID-19
    Program: SRDA
    Duration: 16. 9. 2020 – 31. 12. 2021
  • Relationship between body adiposity and functional properties of arteries in rat
    Program: VEGA
    Duration: 1. 1. 2018 – 31. 12. 2020
  • New regulatory effects of nitric oxide and their role in the development of essential hypertension
    Program: SRDA
    Duration: 1. 7. 2016 – 30. 6. 2020
  • Study of biological effects of H2S/NO products and molecular mechanism of their actions
    Program: SRDA
    Duration: 1. 7. 2016 – 30. 6. 2020
  • Study of critical endogenous biomarkers and signaling pathways in hypertension and cardiovascular diseases
    Program: VEGA
    Duration: 1. 1. 2017 – 31. 12. 2019
  • -
    Program: VEGA
    Duration: 1. 1. 2017 – 31. 12. 2018
  • NO and H2S signal pathways and their interaction in the control of vascular tone during early developmental stage of experimental hypertension
    Program: VEGA
    Duration: 1. 1. 2014 – 31. 12. 2017
  • The efect of nitric oxide and hydrogen sulfide on structure and function of cardiovascular system in normotenzive and hypertenzive rats.
    Program: VEGA
    Duration: 1. 1. 2013 – 31. 12. 2016
  • -
    Program: Other projects
    Duration: 19. 7. 2013 – 31. 12. 2015
  • Study of molecular mechanisms of H2S biological effects.
    Program: SRDA
    Duration: 1. 7. 2012 – 31. 12. 2015
  • The participation of neuronal NO synthase in the regulation of function and structure in cardiovascular system of normotensive and spontaneouly hypertensive rats.
    Program: VEGA
    Duration: 1. 1. 2010 – 31. 12. 2013
  • Etiopatogenesis of compromise blood pressure control: manifestation on structure and function of cardiovascular system.
    Program: VEGA
    Duration: 1. 1. 2009 – 31. 12. 2012
  • Investigation of preventive effect of vasoactive substances on development of structure and function of cardiovascular system in SHR as an experimental model of humen essential hypertension
    Program: VEGA
    Duration: 1. 1. 2006 – 1. 12. 2008
Employees